Juliette Saad
Neurology · Spartanburg, SCNPI 1558441212
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 62.8% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $7,628 and has fallen 98.9% since, to $81 in 2022.
Across 178 payments — averaging $48.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- Biogen$499
- EMD Serono, Inc.$472
- Novartis$419
- Supernus Pharmaceuticals, Inc.$383
- Amgen$224
- plus $1K from 24 others
Across 91 payments — averaging $4790.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Adamas Pharmaceuticals, Inc.$236K
- Novartis$113K
- Alkermes, Inc.$57K
- Biogen$30K
What the payments were for
- Consulting fees$891%
- Speaking & faculty fees$3,47040%
- Travel & lodging$1,63119%
- Food & beverage$3,35039%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $5,381 |
| Biogen | 15 | $499 |
| EMD Serono, Inc. | 13 | $472 |
| Novartis | 25 | $419 |
| Supernus Pharmaceuticals, Inc. | 32 | $383 |
| Amgen | 7 | $224 |
| UCB, Inc. | 9 | $165 |
| Bristol Myers Squibb | 4 | $151 |
| Lilly USA, LLC | 8 | $118 |
| Acorda Therapeutics, Inc | 7 | $110 |
| MDD US Operations, LLC | 5 | $86 |
| Genentech USA, Inc. | 6 | $85 |
| Sanofi | 4 | $75 |
| AbbVie(2 entities) | 4 | $51 |
| CSL Behring | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| Mallinckrodt Enterprises LLC | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Promius Pharma LLC | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Kyowa Kirin, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,569 in reported general payments places this provider in the 75th percentile of 270 neurology providers in South Carolina.
Other neurology in Spartanburg
- Carol KooistraSpartanburg$29K
- Bogdan GheorghiuSpartanburg$23K
- Gonzalo ParesSpartanburg$10K
- John BakerSumter$779K
- Robert CarlileSummerville$428K
- Mary HughesGreenville$404K
- Jose CardenasAiken$216K
- Fredy RevillaGreenville$208K
- Robert AdamsCharleston$204K
- Thomas HughesMt. Pleasant$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.